+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Serotonin Receptor 2 Angonist - Pipeline Insight, 2025 - Product Thumbnail Image

Serotonin Receptor 2 Angonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dermatological Drugs Market 2025-2033 - Product Thumbnail Image

Dermatological Drugs Market 2025-2033

  • Report
  • March 2025
  • 138 Pages
  • Global
From
Albumin Excipient Market Report 2026 - Product Thumbnail Image

Albumin Excipient Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Active Pharmaceutical Ingredients Market Report 2026 - Product Thumbnail Image

Active Pharmaceutical Ingredients Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Protein Therapeutics Market 2024-2028 - Product Thumbnail Image

Protein Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 191 Pages
  • Global
From
Cardiovascular Therapeutics Market 2025-2029 - Product Thumbnail Image

Cardiovascular Therapeutics Market 2025-2029

  • Report
  • March 2025
  • 219 Pages
  • Global
From
Small Molecule Active Pharmaceutical Ingredient Market Report 2026 - Product Thumbnail Image

Small Molecule Active Pharmaceutical Ingredient Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Facial Palsy - Global Strategic Business Report - Product Thumbnail Image

Facial Palsy - Global Strategic Business Report

  • Report
  • April 2026
  • 367 Pages
  • Global
From
Asperger Syndrome - Global Strategic Business Report - Product Thumbnail Image

Asperger Syndrome - Global Strategic Business Report

  • Report
  • April 2026
  • 204 Pages
  • Global
From
Blarcamesine Market - Global Strategic Business Report - Product Thumbnail Image

Blarcamesine Market - Global Strategic Business Report

  • Report
  • April 2026
  • 370 Pages
  • Global
From
Catecholamines - Global Strategic Business Report - Product Thumbnail Image

Catecholamines - Global Strategic Business Report

  • Report
  • April 2026
  • 372 Pages
  • Global
From
Multiple Sclerosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Multiple Sclerosis Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 235 Pages
  • Global
From
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • April 2026
  • 276 Pages
  • Global
From
From
Levodopa Market - Global Strategic Business Report - Product Thumbnail Image

Levodopa Market - Global Strategic Business Report

  • Report
  • April 2026
  • 377 Pages
  • Global
From
From
Loading Indicator